Background
==========

The heart may be conceived as a pump that receives blood from a low-pressure system and raises it to a high-pressure system. Although the mechanism responsible for generation of wall stress (and hence left ventricular (LV) pressure) is contraction of the myocardial fibers, an analytical formulation linking the myocardial and LV dynamics is still lacking. In the absence of this formulation, a popular way of linking LV pressure and volume dynamics is by means of LV compliance (or elastance) \[[@B1],[@B2]\]. Although this yields the cyclic values of elastance and compliance, this concept does not provide an intrinsic measure of elastance and compliance for the contractile state of the LV.

The concept of compliance or elastance was first employed for blood vessels \[[@B3]\], by relating incremental cross-section area (or volume) and transmural pressure. Warner appears to be have been the first to adopt a compliance description for a dynamic heart \[[@B4]\]. In Warner\'s description, a mean value of compliance is adopted for diastolic phase and another mean value for systole, with abrupt transitions between the two states.

Defares \[[@B5]\] avoided the stepwise transition between diastolic and systolic compliance, by making elastance a continuously varying function of time. Later, the concept of a continuously varying compliance or elastance was adopted by a number of investigators with diverse variations \[[@B2],[@B6],[@B7]\]. Nevertheless, they all share the concept of a simple and extrinsic compliance term as an adequate description of ventricular mechanics during the cardiac cycle, based on monitored values of LV pressure and volume.

Classically, ventricular compliance is defined, at any point in time, as the change in ventricular volume concomitant with the change in ventricular pressure, such that

*C*= *dV*/ *dP*, *E*= *dP*/ *dV*    (1)

If C is assumed constant, this equation becomes a linear relation, whose integration gives

*V*= *CP*+ *V*~*c*~    (2)

where V~c~is an integration constant. If the compliance varies with time, then all terms in equation (2) may vary with time, as:

*V*(*t*) - *V*~*c*~(*t*) = *C*(*t*)*P*(*t*)     (3)

In this context, Suga \[[@B8]\] opted for the definition of ventricular elastance as
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to represent the elastance of the contracting LV, where V~d~represents the unstressed LV volume corresponding to zero LV-pressure, obtained by drawing a tangent to P-V curves at end-ejection, as illustrated in Figure [1](#F1){ref-type="fig"}. This model gave rise to the development of the end-systolic pressure-volume relation (ESPVR) as a measure of contractility \[[@B9]-[@B14]\].

![**Schematic drawing of P-V loops and end-systolic P-V relation (ESPVR)**. Schematic drawing of P-V loops and end-systolic P-V relationship (ESPVR) with a positive volume intercept V~d~. The slope of ESPVR line is deemed to be E~max~.](1475-925X-4-10-1){#F1}

However, the determination of the maximal slope E~max~and of the volume-axis intercept (V~d~) of the tangent to the P-V curve at end-ejection (as a measure contractility of the cardiac muscle) is not only unreliable \[[@B11],[@B15]\], but also requires generation of multiple P-V loops under variations loading conditions \[[@B11],[@B15]\]. It is hence impractical to use clinically for a specific LV catheterization-ventriculography data. Above all, all of these variations in the concept of E obtained from LV pressure-volume data fail to explain the phenomena of LV suction and LV pressure drop during early filling as well as the generation of LV pressure increase during isovolumic contraction.

We have hence come up with a new concept of dual passive and active elastances operating throughout the cardiac cycle. The passive elastance (E~p~) represents the LV pressure response to LV volume change (to LV volume increase during LV filling phase and to LV volume decrease during LV ejection phase). However, simultaneously, we also have active elastance (E~a~) representing the contraction of the left ventricle due to its sarcomeric activation (and the development of force between the actin-myosin units) and relaxation (due to disengagement of the actin-myosin units).

LV E~a~develops after the start of isovolumic contraction, becomes maximum some time during late ejection and thereafter decreases and becomes zero during diastolic filling. On the other hand LV E~p~starts increasing after the initiation of LV filling as the LV volume increases. It reaches its maximum value at the end-of-filling phase, remains constant during isovolumic contraction, and thereafter decreases during ejection (as the LV volume decreases). While the generation of E~a~helps us to explain the development of the LV pressure increase during isovolumic contraction, the decrease of E~a~during diastole helps us to explain the decrease in LV pressure during early filling. The incorporation of both E~p~and E~a~helps us to explain the LV pressure changes during the filling and ejection phases.

Methods
=======

Data acquisition
----------------

The subjects in this study were studied in a resting recumbent (baseline) state, after premedication with 100--500 mg of sodium pentobarbital by retrograde aortic catheterization. Left ventricular chamber pressure was measured by a pigtail catheter and Statham P23Eb pressure transducer; the pressure was recorded during ventriculography. Angiography was performed by injecting 30--36 ml of 75% sodium diatrizoate into the LV at 10 to 12 ml/s. It has been found by using biplane angiocardiograms that calculated orthogonal chamber diameters are nearly identical \[[@B16]\]. These findings are used to justify the use of single-plane cine techniques, which allow for beat-to-beat analysis of the chamber dimensions.

For our study, monoplane cineangiocardiograms were recorded in a RAO 30° projection from a 9 in image intensifier using 35 mm film at 50 frames/s using INTEGRIS Allura 9 system at the Nation Heart Centre (NHC), Singapore. Automated LV analysis was carried out to calculate LV volume and myocardial wall thickness. The LV data, derived from the cineangiographic films and depicted in Figure [2](#F2){ref-type="fig"} consists of measured volume and myocardial thickness of the chamber as well as the corresponding pressure. All measurements are corrected for geometric distortion due to the respective recordings systems.

![**A case study of measured LV pressure, volume and wall thickness during a cardiac cycle**. An example of a patient\'s measured LV pressure, volume and wall thickness during a cardiac cycle; t = 0-0.08s is the isovolumic contraction phase, t = 0.08s-0.32s is the ejection phase, t = 0.32s-0.40s is the isovolumic relaxation phase, and t = 0.40s-0.72s is the filling phase. Note that even after 0.4 s, the LV pressure still continues to decrease from 17 mmHg (at 0.4s, at start of filling) to 8 mmHg at 0.44s.](1475-925X-4-10-2){#F2}

In Figure [2](#F2){ref-type="fig"}, it is noted that during the early filling phase, LV pressure decreases even though LV volume increases. This phenomenon is defined as the \'LV suction effect\', which will be explained later by using our concepts of active and passive elastances. This phenomenon is also depicted in Figure [3](#F3){ref-type="fig"} and Table [1](#T1){ref-type="table"}.

![**Relationship between LV volume and pressure for the data of figure 2**. Relationship between LV volume and pressure for the data of Figure 1. Points (21--36) constitute the filling phase, (1--5) constitute the isovolumic contraction phase, (5--17) constitute the ejection phase, and (17--21) constitute the isovolumic relaxation phase. Note that after point 21, the LV pressure decreases; this characterizes LV suction effect.](1475-925X-4-10-3){#F3}

###### 

Computed values of E~a~and E~p~during the cardiac cycle, for subject HEL

  **Point**   **Phase**                **Time**   **Pressure**   **Volume**   **E~a~**       **E~p~**
  ----------- ------------------------ ---------- -------------- ------------ -------------- ----------
  1           Isovolumic contraction   0          18             136.7        0              0.968314
  2                                    0.02       22             135.7        0.051287       0.930811
  3                                    0.04       32             134.6        0.153167       0.891234
  4                                    0.06       52             133.5        0.282331       0.853339
  5                                    0.08       80             132.5        0.424912       0.820289
                                                                                             
  6           Ejection                 0.1        94             129          0.570602       0.714374
  7                                    0.12       103            124.5        0.711775       0.598039
  8                                    0.14       110            119.3        0.843116       0.486996
  9                                    0.16       113            114          0.961299       0.395008
  10                                   0.18       116            107.3        1.06464        0.303159
  11                                   0.2        118            101.8        1.15275        0.243961
  12                                   0.22       120            97.5         1.22616        0.205852
  13                                   0.24       121            94           1.28607        0.179272
  14                                   0.26       122            91           1.334          0.159239
  15                                   0.28       120            88           1.37114        0.141444
  16                                   0.3        116            85.5         1.34002        0.128144
  17                                   0.32       100            84.3         1.15107        0.122212
                                                                                             
  18          Isovolumic relaxation    0.34       74             85           0.846411       0.125638
  19                                   0.36       50             85.5         0.523931       0.128144
  20                                   0.38       30             86.4         0.269515       0.132782
  21                                   0.4        17             90.6         0.113989       0.156743
                                                                                             
  22          Filling                  0.42       10             105          0.0392726      0.276831
  23                                   0.44       8              112          0.0109316      0.365003
  24                                   0.46       8.4            117          0.00244008     0.444703
  25                                   0.48       9              119          0.00043378     0.481259
  26                                   0.5        9.6            120.2        6.10272e-005   0.50462
  27                                   0.52       10.2           121          6.75442e-006   0.520821
  28                                   0.54       10.5           121.4        5.84848e-007   0.529115
  29                                   0.56       10.7           121.6        3.94098e-008   0.533312
  30                                   0.58       10.8           121.8        2.0564e-009    0.537542
  31                                   0.6        11             122          8.2698e-011    0.541805
  32                                   0.62       11.8           124          2.55156e-012   0.586344
  33                                   0.64       12.8           127          6.01397e-014   0.66011
  34                                   0.66       14.5           130.7        1.07837e-015   0.763991
  35                                   0.68       17             134          1.46518e-017   0.87036
  36                                   0.7        20             136.6        1.50271e-019   0.964497
  37                                   0.72       18             136.7        1.15909e-021   0.968314

Definition of passive elastance and active elastance of the LV
--------------------------------------------------------------

At the start of diastolic-filling phase, the LV incremental pressure dP~LV~is the response to (i) LV E~a~continuing to decrease due to the sarcomere continuing to relax well into the filling phase, and (ii) to the rapid inflow of blood and the corresponding increase in LV volume, along with increase in LV E~p~. The associated governing differential equation, relating LV pressure and volume, can be put down (by referring to the Appendix for its derivation) as \[[@B17]\]:
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where *t*represents the time variable (s) from the start of filling phase;

*V*represents the volume of LV (ml) during the filling phase;

*P*~*LV*~represents pressure of the LV, in mmHg (hereafter symbolized by *P*) (mmHg);

*M*represents the inertia term = \[LV wall-density (*ρ*)/(LV surface-area/wall-thickness)\] = *ρh*/ 4*πR*^2^, for a spherical LV model (in mmHg/(ml/s^2^));

*E*represents LV elastance (mmHg/ml).

Likewise during ejection, the LV pressure variation (dP~LV~) is caused by both E~a~variation as well as E~p~decrease. The instantaneous time-varying ventricular elastance (E) is the sum of (i) volume-dependent passive elastance (E~p~) and (ii) active elastance (E~a~) due to the activation of the LV sarcomere. Hence,

*E*= *E*~*a*~+ *E*~*p*~    (6)

We will now provide the expressions for E~p~and E~a~, and then their formulations. The passive (unactivated) myocardium exhibits properties of an elastic material, developing an increasing stress as strain increases, as occurs during ventricular filling. The passive stress-strain relation of myocardial muscle strip is nonlinear, and therefore cannot be described by Hooke\'s law. As an approximation, it follows an exponential relationship \[[@B18]-[@B20]\]. Therefore, the relation between LV passive pressure and volume has also been assumed to be exponential. Since E~p~(= dP/dV) is volume-dependent, we can express it as:
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where *E*~*p*0~is the passive elastance coefficient, *z*~*p*~is the passive elastance exponent, and V is the LV volume; its derivation is provided in a subsequent section.

On the other hand, we will represent E~*a*~as an intrinsic property of the LV (derived later), as:

![](1475-925X-4-10-i6.gif)

where (i) t is measured from the start of isovolumic contraction, (ii) the parameter *E*~*a*0~is the active elastance coefficient, (iii) the time-coefficient (*τ*~*C*~) describes the rate of elastance rise during the contraction phase, while (*τ*~*R*~) describes the rate of elastance fall during the relaxation phase; (iv) the exponents \"*Z*~*C*~\" and \"*Z*~*R*~\" are introduced to smoothen the curvatures of the E~*a*~curve during isovolumic contraction and relaxation phases; (v) the parameter d is a time constant whose (to be determined) value is during the ejection phase, and (vi) u(t-d) is the unit step function, u(t-d) = 0 for t\<d. The rationale for equation (8), as provided in the next section, is based on E~a~incorporating parameters reflecting the (i) generation of LV pressure during isovolumic contraction, (ii) decrease of LV pressure during isovolumic relaxation and early filling, and (iii) the LV pressure-volume relationship during filling and ejection phase.

Our hypothesis
--------------

Based on equations (5--8), our hypothesis is that both E~a~and E~p~contribute to the relationship of LV pressure and volume. While E~p~incorporates LV pressure change due to LV volume change, E~a~incorporates the effect of LV myocardial activation in the generation of LV pressure during the isovolumic phases (when the LV volume remains constant). Since E~a~is deemed to be the basis of LV pressure generation, its variation (as given by equation 8) corresponds to the LV pressure variation.

Determination of E~a~and E~p~expressions
----------------------------------------

### a) Active elastance (during isovolumic contraction and relaxation)

During isovolumic contraction (because dV = 0, ![](1475-925X-4-10-i7.gif) and E~p~is constant), the governing equation (5) becomes *VdE*= *dP*~*LV*~, which can be detailed as:

*V*~*i*~(*E*~*i*~- *E*~*i*-1~) = *V*~*i*~\[(*E*~*a,i*~+ *E*~*p,i*~) - (*E*~*a,i*-1~+ *E*~*p,i*-1~)\] = *V*~*i*~(*E*~*a,i*~+ *E*~*ped*~- *E*~*a,i*-1~- *E*~*ped*~) = *dP*~*LV,i*~    (9)

where i is a time instant during the isovolumic contraction and relaxation, V~i~and P~LV,i~are the monitored LV volume and pressure at this instant, and E~ped~is the passive elastance at the end-diastolic phase.

Also, during isovolumic relaxation (because dV = 0, ![](1475-925X-4-10-i7.gif) and E~p~is constant), the governing equation (5) becomes *VdE*= *dP*~*LV*~, which can be represented as:

*V*~*i*~(*E*~*a,i*~+ *E*~*p,i*~- *E*~*a,i*-1~- *E*~*p,i*-1~) = *V*~*i*~(*E*~*a,i*~+ *E*~*pes*~- *E*~*a,i*-1~- *E*~*pes*~) = *dP*~*LV,i*~    (10)

where E~pes~is the passive elastance at the end-systolic phase

Now, applying equations (9 & 10) to the case shown in the Figure [2](#F2){ref-type="fig"}, we have (using the monitored LV pressure-volume data):

1\. For isovolumic contraction

*E*~*a*,1~= 0     (11-a)

*E*~*a*,2~= (*P*~2~- *P*~1~)/*V*~2~+ *E*~*a*,1~= 0.029477 mmHg/ml     (11-b)

*E*~*a*,3~= (*P*~3~- *P*~2~)/*V*~3~+ *E*~*a*,2~= 0.103771 mmHg/ml     (11-c)

*E*~*a*,4~= (*P*~4~- *P*~3~)/*V*~4~+ *E*~*a*,3~= 0.253584 mmHg/ml     (11-d)

*E*~*a*,5~= (*P*~5~- *P*~4~)/*V*~5~+ *E*~*a*,4~= 0.463599 mmHg/ml     (11-e)

2\. For isovolumic relaxation

*E*~*a*,18~= (*P*~18~- *P*~17~)/*V*~18~+ *E*~*a*,17~= *E*~*a*,17~- 0.058954 mmHg/ml     (11-f)

*E*~*a*,19~= (*P*~19~- *P*~18~)/*V*~19~+ *E*~*a*,18~= *E*~*a*,17~- 0.177824 mmHg/ml     (11-g)

*E*~*a*,20~= (*P*~20~- *P*~19~)/*V*~20~+ *E*~*a*,19~= *E*~*a*,17~- 0.312656 mmHg/ml     (11-h)

*E*~*a*,21~= (*P*~21~- *P*~20~)/*V*~21~+ *E*~*a*,20~= *E*~*a*,17~- 0.463599 mmHg/ml     (11-i)

Now in the above expressions 11(f-i), E~a,17~at end-ejection is unknown. For different representative values of E~a,17~, we can get different E~a~curves. We need to determine the optimal value of E~a,17~, such that E~a~can be described by a smooth curve to fit both isovolumic contraction and ejection phases. In Figure [4](#F4){ref-type="fig"}, we have determined E~a,17~= 1.1 mmHg/ml, and the polynomial expression for E~a~(t) to fit its above calculated values during isovolumic contraction and relaxation. However, in order to (i) more suitably represent E~a~to correspond with its role during the cardiac phases (isovolumic, ejection and filling), and (ii) because of the sigmoidal shape of E~a~curve and its variation resembling the LV pressure variation during systole (as seen in Figure [4](#F4){ref-type="fig"}), we express E~a~(according to equation 8) as:

![**E~a~vs. time for the data of figure 2.**Points (1--5) are the computed values of E~a~during isovolumic contraction phase, based on equations 11(a-e). In the isovolumic relaxation phase, the computed values are represented by the symbol Δ, for *E*~*a*,17~= 1.1 *mmHg/ml*. The best fit for E~a~during isovolumic contraction and relaxation phase is given by the curve: *E*~*a*~= -12000*t*^6^+ 17000*t*^5^- 7700*t*^4^+ 1100*t*^3^+ 19*t*^2^+ 0.59*t*+ 0.00056](1475-925X-4-10-4){#F4}
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So that its constituent parameters have physiological significance as indicated following equation (8).

Hence, to compute E~a~(s) during isovolumic contraction, when u(t-d) = 0, we employ the expression

![](1475-925X-4-10-i9.gif)

and determine its parameters E~a0~, *τ*~*C*~and Z~C~to fit the monitored pressure-volume data. Then, to compute E~a~(s) during isovolumic relaxation, we employ the total expression

![](1475-925X-4-10-i10.gif)

and determine its remaining parameters d, *τ*~*R*~and Z~R~to fit the measured pressure-volume data.

For the sample data of Figure [2](#F2){ref-type="fig"}, the variation of E~a~is depicted in Figure [5](#F5){ref-type="fig"}, along with the values of its parameters. We now propose that E~a~can be employed as an index of contractility.

![**The data of figure 2 is fitted with equation (8).**When the patient data of Figure 2 is fitted with equation (8), the resulting parameters values are obtained as: *E*~*a*0~= 1.48 mmHg/ml, *τ*~*C*~= 0.1555 s, *Z*~*C*~= 1.631, d = 0.28 s, *τ*~*R*~= 0.07935 s, *Z*~*R*~= 2.267 s, *E*~*a*,17~= 1.1 mmHg/ml, RMS = 0.026 mmHg/ml.](1475-925X-4-10-5){#F5}

### b) Passive elastance determination during diastolic filling

During the diastolic filling phase, equation (5) becomes

![](1475-925X-4-10-i11.gif)

Now because E~p~is constant at a particular volume V~i~, equation (13) becomes

![](1475-925X-4-10-i12.gif)

![](1475-925X-4-10-i13.gif)

where i is a time-instant during diastolic filling, V~i~and P~LV,i~are the monitored LV volume and pressure at this time, and *M*= *ρh*/ 4*πR*^2^. For the patient data (shown in Figure [2](#F2){ref-type="fig"}), we can get the mean value for M during diastolic filling, *M*= 8.03 × 10^-6^*mmHg/(ml/s^2^*). Therefore, from equation (15), we can calculate the values of E~p~at various instants during filling phase. We then plot E~p~vs V, in Figure [6](#F6){ref-type="fig"}. By fitting equation (7) to these calculated values of E~p~, we obtain the values of the parameters *E*~*p*0~and *z*~*p*~, as:

![**Passive elastance E~p~vs LV volume for the data of figure 2**. Passive elastance E~p~vs LV volume V, for the sample case shown in Figure 2.](1475-925X-4-10-6){#F6}

*z*~*p*~= 0.0395 *ml*^-1^, *E*~*p*0~= 4.375 × 10^-3^*mmHg*/ *ml*    (16)

and the E~p~function (corresponding to its expression given by equation 7) as follows:

*E*~*p*~= 4.375 × 10^-3^*e*^0.0395*V*^    (17)

We now propose to adopt E~p~as a measure of LV resistance-to-filling.

Hence during ejection, both E~a~and E~p~are varying. During ejection and filling phases, E~p~can be calculated at any time using equation (17). Likewise, E~a~can be calculated during ejection and filling phases using equation (8), once its parameters have been determined by employing equation (12-b & 12-b) during isovolumic contraction and relaxation phases. Their values during the cardiac cycle are listed in Table [1](#T1){ref-type="table"}.

Clinical application results
============================

The analyses, presented herewith, are now applied to clinically obtained data consisting of the subject\'s left ventricular (instant-to-instant) dimensions (obtained by cineangiocardiograph) and chamber pressure (obtained by cardiac catheterization). For each subject, passive and active elastances are determined from the left ventricular data. Table [2](#T2){ref-type="table"} provides the measured data and the model-derived parameters for three subjects (subject HEL, DDM, and ML). Subject HEL serves as a sample patient with myocardial infarct, subject DDM with double vessel disease (DVD) and hypertension, treated with PTCA; subject ML with idiopathic myocardial hypertrophy (IMH).

###### 

Clinical history, measured hemodynamic data and calculated passive and active elastance parameters (E~p~and E~a~) for subjects (HEL, DDM and ML). Where LVP: left ventricle chamber pressure, AOP: aortic pressure, EDV: end-diastolic volume, ESV: end-systolic volume, EF: ejection fraction, MI: myocardial infarct, DVD: double vessel disease, HTN: hypertension, IMH: idiopathic myocardial hypertrophy, *E*~*a*,max~: maximum active elastance

  **Subject**               **H.E.L**        **D.D.M**       **M.L**
  ------------------------- ---------------- --------------- ----------------
  Disease                   MI, DVD          DVD, HTN        IMH
  LVP (mmHg)                122/18           170/24          109/12
  AOP (mmHg)                125/75           169/99          115/70
  EDV/ESV (ml)              132.5/84.3       121.7/41.3      368/284
  EF                        0.36             0.66            0.23
  *E*~*p*0~(mmHg/ml)        4.375 × 10^-3^   6.74 × 10^-5^   1.442 × 10^-8^
  *z*~*p*~(ml^-1^)          0.0395           0.07499         0.05024
  *E*~*a*0~(mmHg/ml)        1.48             4.4             0.595
  *τ*~*C*~(s)               0.1555           0.207           0.1082
  *Z*~*C*~                  1.631            1.536           1.977
  d (s)                     0.28             0.26            0.18
  *τ*~*R*~(s)               0.07935          0.1536          0.1377
  *Z*~*R*~                  2.267            2.943           1.873
  *E*~*a*,max~(mmHg/ml)     1.37             3.58            0.57
  *dP*/ *dt*~max~(mmHg/s)   1200             1475            1125

The variations of model-derived nonlinear passive and active elastances for the subject HEL are shown in Figure [7](#F7){ref-type="fig"}. For this particular subject (HEL), the maximum active elastance is 1.37 mmHg/ml. In Figure [8](#F8){ref-type="fig"}, we have plotted E~a~vs incremental pressure (P-P~ed~) for this patient HEL. Note that the elastance is much higher at late-ejection than early ejection. This is because of a continuing sarcomere stress development and shortening. The active elastance reaches its maximum value at late-ejection (point 15), and thereafter decreases. However as shown in Figure [7](#F7){ref-type="fig"}, even after the end of relaxation phase (point 21) the active elastance continue to decrease into the filling phase. This decrease can explain the suction effect during the rapid filling sub-phase, even after LV filling has commenced.

![**Pressure, active elastance E~a~, and passive elastance E~p~and total E = E~a~+ E~p~for the data of figure 2.**Pressure, active elastance E~a~, passive elastance E~p~, and total *E*= (*E*~*a*~+ *E*~*p*~) for the sample subject shown in Figure 2. In this figure, 1--5 represents the isovolumic contraction phase, 5--17 represents the ejection phase, and 17--21 represents the isovolumic relaxation phase, 21--37 represents the diastolic filling phase.](1475-925X-4-10-7){#F7}

![**Active elastance vs. incremental pressure.**Active elastance vs. incremental pressure (P-P~ed~) for the same subject as shown in Figure 2. The arrow direction indicates progression of time; 1--5: isovolumic contraction phase; 5--17: ejection phase. Note the rapid decrease in E~a~during the isovolumic relaxation that also extends into the filling phase, and causes suction of blood into the LV even before initiation of left-atrial contraction.](1475-925X-4-10-8){#F8}

Figures [9](#F9){ref-type="fig"} and [10](#F10){ref-type="fig"} provide representations of the nonlinear passive and active elastance for subject HEL (with hypertension), DDM (myocardial infarct), and ML (idiopathic myocardial hypertrophy). The E~p~vs LV volume plots, in Figure [9](#F9){ref-type="fig"}, clearly reveal that E~p~increases exponentially with increase LV volume; the parameters (*E*~*P*0~and *z*~*p*~) characterize this relationship. The passive elastance curve is steeper for a stiffer myocardium, with a corresponding bigger value of the exponential coefficient *Z*~*p*~(subject ML). The E~a~vs incremental pressure (P-P~ed~) plots, in Figure [10](#F10){ref-type="fig"}, reveal the development and decrease of E~a~during systole, which in turn governs the generation of LV pressure.

![**LV volume and corresponding volume-dependent passive elastance.**Volume-dependent passive elastance (E~p~) for subjects HEL, DDM, and ML.](1475-925X-4-10-9){#F9}

![**Active elastance vs. incremental pressure.**Active elastance vs. incremental pressure for subjects HEL, DDM, and ML.](1475-925X-4-10-10){#F10}

Discussion
==========

Ea as a contractility index
---------------------------

Yet another way to study E~a~variation is by means of the E~a~vs normalized time (t/t~s~) plot, shown in Figure [11](#F11){ref-type="fig"}. These two figures [10](#F10){ref-type="fig"} and [11](#F11){ref-type="fig"} make us realize that E~a,max~could be regarded as an index of LV contractility. Hence, we decided to plot E~a,max~vs the traditional contractility indices of EF and (dP/dt)~max~. These plots are displayed in Figures [12](#F12){ref-type="fig"} and [13](#F13){ref-type="fig"}. It is noted that E~a,max~has a high degree of correlation with both EF and (dP/dt)~max~. It is interesting to compare our correlation-coefficient value (0.8972) with the value of 0.89 obtained by Mehmel et al \[[@B12]\], although this paper computes elastance as an extrinsic property = \[P/(V-V~d~)\]~es~.

![**Active elastance vs. normalized time.**Active elastance vs normalized time (t/t~s~) for subjects HEL, DDM, and ML. Herein, t~s~is the duration from start-of-isovolumic contraction phase to end-of-isovolumic relaxation.](1475-925X-4-10-11){#F11}

![**E~a,max~vs EF.**Relating our contractility index E~a,max~to EF factor, with r being the correlation coefficient.](1475-925X-4-10-12){#F12}

![**E~a,max~vs dP/dt~max~.**Relating our contractility index E~a,max~to the traditional contractility index dP/dt~max~, with r being the correlation coefficient.](1475-925X-4-10-13){#F13}

Demonstrating LV suction phenomenon
-----------------------------------

The active elastance curve can explain some critical LV physiological phenomena, namely LV pressure generation during isovolumic contraction and LV suction during early filling. The rapid decrease in elastance during isovolumic relaxation extends into the filling phase, and can explain the decrease in LV pressure (in Figure [7](#F7){ref-type="fig"}) even after LV filling has commenced. Let us show how this happens, by rewriting equation (15) as follows:

P~i~- P~i-1~= (E~p,i~+ E~a,i~)(V~i~- V~i-1~) + V~i~(E~a,i~- E~a,i-1~)     (18)

by neglecting the ![](1475-925X-4-10-i14.gif) term, based on the calculation of its value being of the order of 10^-2^compared to (i) (*E*~*p,i*~+ *E*~*a,i*~)(*V*~*i*~- *V*~*i*-1~), which is of the order of 10^0^and (ii) *V*~*i*~(*E*~*a,i*~- *E*~*a,i*-1~) which is the order of 10^1^.

In equation (18), it is seen that P~i~can be less than P~i-1~(or that P~i~- P~i-1~\< 0) only if (E~a,i~- E~a,i-1~) is negative, i.e., active elastance is decreasing. Now for subject H.E.L (Figure [1](#F1){ref-type="fig"}), the computed values of E~a~and E~p~at these 2 instants (based on equations 8 & 17) are:

*E*~*p*,22~= 0.2768 *mmHg/ml*, *E*~*a*,22~= 0.0393 *mmHg/ml*, *E*~*a*,21~= 0.1140 *mmHg/ml*, *V*~22~= 105 *ml*, *V*~21~= 90.6 *ml*    (19)

Substituting these values into equation (18) gives (*P*~22~- *P*~21~) = -3.22 *mmHg*, confirming decrease of pressure during early filling.

Hence, our novel concept of \"decreasing E~a~during the early phase of filling\" enables us to explain the phenomenon of decreasing LV pressure during the early stage of filling. In other words, it is suggested that the sarcomere actin-myosin activity continues into the filling phase. The decreasing E~a~during the filling phase seems to reflect decreasing sarcomeric activity during filling. Likewise, the increase in E~a~during isovolumic contraction is responsible for increase in LV pressure at constant volume, as demonstrated by means of equation (11).

Demonstrating variation of LV pressure during ejection in terms of E~a~and E~p~
-------------------------------------------------------------------------------

Similarly, both the active and passive elastances can explain LV pressure variation during ejection, using equation (18). Let us show how this happens by just taking two instants (t~10~& t~9~), as follows:

P~10~- P~9~= (E~p,10~+ E~a,10~)(V~10~- V~9~) + V~10~(E~a,10~- E~a,9~)     (20)

Substituting these computed values (listed in Table [1](#T1){ref-type="table"}) into equation (20) gives *P*~10~- *P*~9~= 1.92 *mmHg*, which is approximately equal to the actual value of 2 mmHg.

Concluding comments
===================

Previous works have described elastance as a derived parameter from LV pressure-volume data, based on the definition of *P*/ (*V*- *V*~*d*~) \[[@B9],[@B10],[@B12]-[@B14]\]. Also, E~max~(given by ESPVR) as illustrated on Figure [1](#F1){ref-type="fig"} varies with different arterial loading states and is therefore load dependent \[[@B21]\], and not an intrinsic index independent of LV loading states.

Our definitions of E~p~and E~a~enable us to explain the phenomena of (i) LV suction during early filing, (ii) LV pressure rise during isovolumic contraction (iii) LV pressure variation during the ejection phase, and (iv) LV pressure drop during the relaxation phase. Both the concepts of E~a~and E~p~are made possible by our redefining elastance and compliance as

*dP*= *d(EV)*= *d(V/C)*= *VdE*+ *EdV*    (21)

Our concept of E~a~enables us to explain (i) the generation of pressure during isovolumic contraction and decrease of pressure during isovolumic relaxation, when the volume is constant, and (ii) the decrease of pressure during the rapid filling phase.

Our concept of decreasing E~a~along with increasing E~p~during filling, which enables us to explain the LV suction effect during early filling, is indirectly supported by the work of Shoucri \[[@B22]\]. He has indicated that the LV wall stress during the filling phase is made up of two components: (i) a passive increasing component due to LV pressure and (ii) an active decreasing component due to decreasing active fiber stress.

However, the determination of this active fiber stress in his paper is empirical and not based on a well-defined concept and expression for E~a~, as provided by us.

Finally, both E~a~and E~p~are invoked to explain the variations of pressure during the ejection and filling phases. From the viewpoint of intrinsic indices of LV assessment, E~p~can represent LV myocardial stiffness property and resistance to LV filling. On the other hand, E~a~has been shown to correspond to LV contractility, by means of Figures [12](#F12){ref-type="fig"} & 13. Therein, we have shown a high degree of correlation between E~a,max~and (dP/dt)~max~as well as EF.

In future, we can also couple our LV model (of E~p~and E~a~) with an arterial lumped-parameter model (consisting of total peripheral resistance R, total arterial compliance C, aortic characteristic impedance Z~0~and inertial L) in order to simulate and explain the mechanisms of chronic hypertensive states \[[@B23]\], in terms of alteration in E~*a*~itself as a measure of LV adaptation to chronic hypertension induced in the circulation system.

Appendix: Derivation of Equation (5)
====================================

Dynamic equilibrium of the LV myocardial element gives (based on figure [14](#F14){ref-type="fig"}):

![**Dynamic equilibrium of a myocardial element.**Dynamic equilibrium of a myocardial element. Element mass *m*~*e*~= *ρ*(2*r*~1~*dθ*~1~)(2*r*~2~*dθ*~2~)*h*= (*ρh*)(4*r*~1~*r*~2~*dθ*~1~*θ*~2~) = *ρhA*~*e*~= *m*~*s*~*A*~*e*~; *dσ*~*i*~= (*dP*~*el*~)(*r*~*i*~) / (2*h*), (i = 1, 2); *dP*~*el*~is the incremental elastic-recoil pressure. For dynamic equilibrium of the myocardial element, *m*~*e*~![](1475-925X-4-10-i15.gif) + 2(*dσ*~1~)(2*r*~2~*dθ*~2~*h*) + 2(*dσ*~2~)(2*r*~1~*dθ*~1~*h*) - *A*~*e*~*dP*~*LV*~= 0, or *m*~*e*~![](1475-925X-4-10-i15.gif) + *A*~*e*~*dP*~*el*~- *A*~*e*~*dP*~*LV*~= 0. For our LV spherical geometry model, r~1~= r~2~and *dσ*~1~= *dσ*~2~.](1475-925X-4-10-14){#F14}

![](1475-925X-4-10-i16.gif)

where the myocardial element mass, *m*~*e*~= *m*~*s*~*A*~*e*~, *m*~*s*~(the myocardial surface-density or mass per unit surface area) = *ρh*, *ρ*is the myocardial density, and u is the radial displacement, *dP*~*el*~and *dP*~*LV*~are the incremental elastic-recoil and left ventricular pressures (as depicted in Figure A-1).

Now since,

![](1475-925X-4-10-i17.gif)

By assuming *r*~1~= *r*~2~= *R*

![](1475-925X-4-10-i18.gif)

we can write:

![](1475-925X-4-10-i19.gif)

where *ρ*~*s*~is the surface density, *M*= *ρ*~*s*~*h*, and V is the LV volume. Now, referring to Figure A-1,

![](1475-925X-4-10-i20.gif)

and

![](1475-925X-4-10-i21.gif)

where *R*~*e*~is the resistance to LV filling (through the open mitral-valve), *ρ*~*f*~is the blood density and *v*is the blood velocity at site 2.

![](1475-925X-4-10-i22.gif)

Let us now define incremental elastic recoil pressure (in response to incremental LV pressure *dP~*LV*~*) as:

![](1475-925X-4-10-i23.gif)

Hence, from equations (A-1, A-4, A-7 & A-8), we have

![](1475-925X-4-10-i24.gif)
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Introducing the term elastance (= 1/C), we can put down

![](1475-925X-4-10-i26.gif)
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